Asbestos and Meso Research | Science Advisory Board | Raffit Hassan, MD

This Meso Foundation’s Science Advisory board works to raise continued awareness about the need for mesothelioma and asbestos research. Led by some of the best mesothelioma specialists in the field, the Board serves as a resource for patients and families, helping to offer an outlet for education as well as striving to improve mesothelioma treatment options.

Among those on our board of mesothelioma and asbestos research experts is Dr. Raffit Hassan.

Meet Raffit Hassan, MD - Immediate Past Chairman

Mesothelioma and Asbestos Research Experts: Raffit Hassan, MD  

Dr. Hassan, is an Investigator and Chief of the Solid Tumor Immunotherapy Section in the Laboratory of Molecular Biology at the National Cancer Institute. Dr. Hassan is a medical oncologist whose laboratory and clinical research is focused on developing novel therapies for the treatment of mesothelioma. Work done by him and his collaborators has shown that mesothelin, a tumor antigen which was discovered at the NCI, is a useful target for tumor-specific therapy of malignant mesothelioma. His group is presently conducting clinical trials of three different agents targeting mesothelin namely, SS1P an anti-mesothelin immunotoxin, MORAb-009 a chimeric anti-mesothelin monoclonal antibody and CRS-207 a mesothelin tumor vaccine.

Contact Info for Raffit Hassan, MD
National Cancer Institute
Building 37, Room 5116
Bethesda, MD 20892


Believe in a Cure!

Contact us here for immediate expert help and a free copy of the book "100 Questions & Answers About Mesothelioma."

(877) END-MESO
(877) 363-6376